Johnson & Johnson recently announced that the company has stopped a clinical trial of a new Alzheimer’s disease drug due to certain safety issues. This is another failed clinical trial following the announcement of several large clinical trials that have no effect in treating Alzheimer’s disease. More and more failure cases tell us that we need to stop and think about how we could find the cause of Alzheimer’s disease….